SV

Street Verdict

Analyst Scorecard

A record of what Raja Venkatraman said publicly, with the source. Not advice.

“Recommends buying Aarti Pharmalabs above ₹742 with a stop loss at ₹725 and a target of ₹825. The stock delivered stable Q3 results despite volatility, and its resilience suggests a strong breakout as buying momentum builds, with RSI above 70 indicating sustained upward trends.”

Raja Venkatraman’s track record (trackable calls only): 616 graded calls · 95% CI 35–43%

Aarti Pharmalabs LtdBullishCalled 11 Feb 2025Graded 03 Mar 2025
Verdict:MISS

How this call is judged

A call is judged on closing prices only: a close at its target is a hit and a close at its stop is a miss. A call that states an entry starts at the first close that reaches it; if none does in the days allowed, it was never triggered, is not graded and counts toward no hit rate. No time frame is stated and the call gives both a target and a stop, so it is tracked until a close reaches one of them (rule H6): the target first is a hit, the stop first a miss, and until then it stays open.

Entry: ₹742, as stated.

Target ₹825, stop ₹725, as stated.

No time frame is stated, so it is tracked until a close reaches ₹825 or ₹725: there is no fixed window.

The stop ₹725 was reached on a close before the target ₹825. Miss.

The grader’s working: R3 TRADE_SETUP: entered ₹791 on 2025-02-17 (stated entry ₹742, BREAKOUT entry, filled); stop ₹725 breached at close ₹718.1 on 2025-03-03. No time frame is stated and the call gives both a target and a stop, so it is tracked until a close reaches one of them (rule H6): the target first is a hit, the stop first a miss, and until then it stays open.

Tracking Aarti Pharmalabs Ltd since this call

1-year tracking window
Read the original articleSee Raja Venkatraman’s full track record